How to Handle CAR-T Waitlists in Multiple Myeloma

In this latest episode of ASTCT Talks, Christina Ferraro, MSN, APRN-CNP, BMTCN, is joined by Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO, to discuss criteria used to determine who is eligible for CAR-T cells, efforts between multi-disciplinary teams to select patients, ethical implications in patient selection and more.
About Christina Ferraro
Christina Ferraro completed her bachelor of science in nursing at The Ohio State University in 2001 and received a master of science in nursing and certification as a family nurse practitioner from Kent State University in 2016. She joined the Cleveland Clinic in 2003 as a registered nurse on the inpatient blood and marrow transplant unit and became an outpatient BMT nurse coordinator in 2006. Christina has been leading the Victor Fazio, MD BMT Cancer Survivorship Program at the Cleveland Clinic since 2016 and has experience in seeing patients with graft-versus-host disease and patients in long-term follow up, emphasizing patient empowerment, education and support.
Christina has presented at numerous regional and national conferences including the Oncology Nursing Conference, Leukemia & Lymphoma Society, BMT Infonet, American Society of Transplantation and Cellular Therapy meetings, and Cleveland Clinic nursing grand rounds. Christina is an active author, presenter and educator on the topic of BMT and survivorship and participates in research focused on survivorship and post-transplant complications.
About Beth Faiman
Dr. Faiman is an exemplary leader in cancer nursing, conducting innovative research and integrating new medical knowledge into nursing practices. She is a founding member of the International Myeloma Foundation Nurse Leadership Board and co-developed nurse-led consult clinics to expedite diagnosis and management of thrombosis and plasma cell disorders.
She is an adult nurse practitioner in the Department of Hematology/Oncology at the Cleveland Clinic. Dr. Faiman has influenced cancer care practice by presenting at international and US national conferences, serving as lecture chair, and receiving numerous awards and accolades. She is a Distinguished Fellow in the American Academy of Nursing and holds an appointment on the American Board of Internal Medicine Hematology maintenance of certification committee. She is editor of the Blood and Marrow Transplant certified Nurse (BMTCN) review manual and editor-in-chief of Journal of the Advanced Practitioner in Oncology (JADPRO).
This episode was sponsored by Janssen Oncology and Legend Biotech.